Literature DB >> 3371984

Thromboangiitis obliterans with eosinophilia (Buerger's disease) of the temporal arteries.

J T Lie1, C J Michet.   

Abstract

Thromboangiitis obliterans (Buerger's disease) is a nonatherosclerotic, inflammatory, occlusive vascular disease occurring almost exclusively in young male smokers. It involves principally medium sized and small arteries and veins of the lower and upper extremities, and only rarely the visceral and cerebral blood vessels. Buerger's disease of the temporal arteries, unassociated with the involvement of blood vessels of either the upper or lower extremities has not been previously reported. Three such cases, clinically mimicking the classic (giant cell) temporal arteritis of the elderly, are described. This unusual arterial lesion also bears some resemblance to subcutaneous angiolymphoid hyperplasia with eosinophilia (Kimura's disease).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371984     DOI: 10.1016/s0046-8177(88)80212-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

Review 1.  Rheumatologic disease with peripheral eosinophilia.

Authors:  Nüket Bavbek; Ayşe Kargili; Handan Cipil; Ali Koşar; Yaşar Karaaslan
Journal:  Rheumatol Int       Date:  2004-04-20       Impact factor: 2.631

Review 2.  Eosinophilia in rheumatologic diseases: a prospective study of 1000 cases.

Authors:  Ayşe Kargili; Nüket Bavbek; Arif Kaya; Ali Koşar; Yaşar Karaaslan
Journal:  Rheumatol Int       Date:  2004-04-06       Impact factor: 2.631

Review 3.  Evaluation and differential diagnosis of marked, persistent eosinophilia.

Authors:  Thomas B Nutman
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

4.  Development of Eosinophilic Temporal Arteritis and Digital Ischemia in a Patient with Hypereosinophilic Syndrome.

Authors:  Kayo Ishii; Takahiro Mizuuchi; Yusuke Yamamoto; Hiroaki Mori; Mayu Tago; Eri Kato; Haeru Hayashi; Koichiro Tahara; Tetsuji Sawada
Journal:  Intern Med       Date:  2020-02-26       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.